Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00558272 | Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease | completed | Phase 2 | 139 | AstraZenecaINDUSTRY | 8 | May 27, 2013 | clinicaltrials |
| NCT01218243 | An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia | completed | Phase 2 | 100 | Guang'anmen Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | May 27, 2013 |
| clinicaltrials |
| NCT00608920 | Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping(SPECT) | completed | N/A | 15 | Washington University School of MedicineOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT01733836 | Prostate Cancer Active Surveillance Metformin Trial | withdrawn | Phase 2 | 0 | University Health Network, TorontoOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT00182052 | Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer | completed | Phase 3 | 100 | Massachusetts General HospitalOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT00710658 | Internet Support for Cancer Patients(WebChoice) | completed | N/A | 325 | Oslo University HospitalOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT01215513 | Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients | completed | Phase 3 | 127 | Ferring PharmaceuticalsINDUSTRY | 1 | May 22, 2013 | clinicaltrials |
| NCT00077402 | Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer | completed | Phase 2 | 50 | Cancer Therapeutics Research GroupOTHER | 3 | May 15, 2013 | clinicaltrials |
| NCT00087347 | Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer | completed | — | 14 | Massachusetts General HospitalOTHER | 1 | May 14, 2013 | clinicaltrials |
| NCT00381173 | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | completed | Phase 1 | 22 | Eisai Inc.INDUSTRY | 1 | May 14, 2013 | clinicaltrials |
| NCT00702104 | Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area | completed | — | — | University of California, San FranciscoOTHER | 1 | May 14, 2013 | clinicaltrials |
| NCT00060255 | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 451 | Roswell Park Cancer InstituteOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT00136526 | Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer | completed | Phase 2 | 30 | University of WashingtonOTHER | 0 | May 9, 2013 | clinicaltrials |
| NCT00095667 | Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | May 8, 2013 | clinicaltrials |
| NCT01826565 | Comparison of Two Insertion Technique of I-gel(I-gel90) | unknown | N/A | 100 | Seoul National University HospitalOTHER | 0 | May 6, 2013 | clinicaltrials |
| NCT00005073 | Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms | terminated | Phase 3 | 544 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00043212 | Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. | withdrawn | Phase 3 | 0 | Northwest BiotherapeuticsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00403000 | Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | completed | Phase 2 | 27 | Roswell Park Cancer InstituteOTHER | 1 | May 1, 2013 | clinicaltrials |
| NCT00385580 | Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer | completed | Phase 2 | 94 | Bristol-Myers SquibbINDUSTRY | 3 | Apr 30, 2013 | clinicaltrials |
| NCT01020604 | PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients(PROTECT-Z) | completed | — | 1,376 | AstraZenecaINDUSTRY | 1 | Apr 30, 2013 | clinicaltrials |
| NCT00577980 | Testosterone in Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 29, 2013 | clinicaltrials |
| NCT01839994 | Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer | unknown | Phase 3 | 350 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Apr 25, 2013 | clinicaltrials |
| NCT00691977 | Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate | withdrawn | Phase 1 | 0 | Virginia Commonwealth UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01664728 | An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 | completed | Phase 1 | 54 | Janssen Research & Development, LLCINDUSTRY | 1 | Apr 19, 2013 | clinicaltrials |
| NCT00600535 | A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer | completed | Phase 1 | 31 | Cougar Biotechnology, Inc.INDUSTRY | 2 | Apr 17, 2013 | clinicaltrials |
| NCT00924469 | A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer | completed | Phase 2 | 58 | Janssen Research & Development, LLCINDUSTRY | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00011349 | Early Stage Prostate Cancer Cohort | completed | — | 1,116 | US Department of Veterans AffairsFED | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00897793 | Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | completed | — | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00910754 | A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 33 | Janssen Research & Development, LLCINDUSTRY | 2 | Apr 12, 2013 | clinicaltrials |
| NCT01017939 | A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 34 | Janssen Research & Development, LLCINDUSTRY | 2 | Apr 12, 2013 | clinicaltrials |
| NCT00313781 | Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC) | completed | Phase 2 | 204 | PfizerINDUSTRY | 6 | Apr 11, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01012141 | Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer(PROTAXY) | completed | Phase 2 | 30 | Centre Jean PerrinOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01827813 | Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies | completed | N/A | 74 | TC Erciyes UniversityOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00258466 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | withdrawn | Phase 3 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 8, 2013 | clinicaltrials |
| NCT00003626 | Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00243048 | Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 70 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01825642 | Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer | completed | Phase 2 / Phase 3 | 140 | University of MichiganOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00039299 | Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00046826 | Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy | completed | Phase 2 | — | Nuvance HealthOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00060372 | Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT01819285 | Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer | completed | Phase 3 | 985 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Mar 27, 2013 | clinicaltrials |
| NCT00003408 | Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer | completed | Phase 2 | 40 | Cancer Treatment Centers of AmericaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00005623 | Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer | completed | Phase 3 | — | Barr LaboratoriesINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00036933 | Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT01814150 | The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel | unknown | — | 200 | Gottfried MayaOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT00004211 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 17 | Duke UniversityOTHER | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00010127 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | terminated | Phase 1 | 3 | Duke UniversityOTHER | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00451958 | A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy | completed | Phase 3 | 386 | Ferring PharmaceuticalsINDUSTRY | 12 | Mar 21, 2013 | clinicaltrials |
| NCT00666926 | Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms | completed | Phase 1 | 99 | Verastem, Inc.INDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 27, 2013source: clinicaltrials